Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Life Sciences
Global Pharmaceuticals: 2018 industry statistics
By
Dr Martin Hall
09 Apr 2019
genedrive Plc
Life Sciences
First commercial sales in new focus area: bio-threats
08 Apr 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Oxford BioMedica
Life Sciences
Deal-making drives first annual profit
02 Apr 2019
Allergy Therapeutics plc
Life Sciences
Take an objective view
18 Mar 2019
Allergy Therapeutics plc
Life Sciences
Strong operating performance driving market share
06 Mar 2019
Collagen Solutions Plc
Life Sciences
Exciting growth
By
Dr Martin Hall
22 Feb 2019
Yourgene Health
Life Sciences
EBITDA-positive in fiscal 2020
22 Feb 2019
Yourgene Health
Life Sciences
Transformed and de-risked
19 Feb 2019
Avacta Group plc
Life Sciences
A second wake-up call for the market
06 Feb 2019
Shield Therapeutics Plc
Life Sciences
Cast-iron investment
By
Dr Martin Hall
28 Jan 2019
Advanced Oncotherapy
Life Sciences
Important regulatory milestone: ISO approval
21 Jan 2019
Prev
1
...
9
10
11
12
13
...
22
Next
